140 related articles for article (PubMed ID: 16455602)
1. Influence of enzymes and surfactants on the disintegration behavior of cross-linked hard gelatin capsules during dissolution.
Pennings FH; Kwee BL; Vromans H
Drug Dev Ind Pharm; 2006 Jan; 32(1):33-7. PubMed ID: 16455602
[TBL] [Abstract][Full Text] [Related]
2. The Effect of Enzymes and Sodium Lauryl Sulfate on the Surface Tension of Dissolution Media: Toward Understanding the Solubility and Dissolution of Carvedilol.
Hamed R; Alnadi SH; Awadallah A
AAPS PharmSciTech; 2020 May; 21(5):146. PubMed ID: 32435989
[TBL] [Abstract][Full Text] [Related]
3. Effect of sodium lauryl sulfate in dissolution media on dissolution of hard gelatin capsule shells.
Zhao F; Malayev V; Rao V; Hussain M
Pharm Res; 2004 Jan; 21(1):144-8. PubMed ID: 14984269
[TBL] [Abstract][Full Text] [Related]
4. Cross-linking of hard gelatin carbamazepine capsules: effect of dissolution conditions on in vitro drug release.
Marchais H; Cayzeele G; Legendre JY; Skiba M; Arnaud P
Eur J Pharm Sci; 2003 Jun; 19(2-3):129-32. PubMed ID: 12791415
[TBL] [Abstract][Full Text] [Related]
5. Effect of Four Commonly Used Dissolution Media Surfactants on Pancreatin Proteolytic Activity.
Guncheva M; Stippler E
AAPS PharmSciTech; 2017 May; 18(4):1402-1407. PubMed ID: 27586964
[TBL] [Abstract][Full Text] [Related]
6. Enzymes in the dissolution testing of gelatin capsules.
Marques MR
AAPS PharmSciTech; 2014 Dec; 15(6):1410-6. PubMed ID: 24942315
[TBL] [Abstract][Full Text] [Related]
7. Influence of capsule shell composition on the performance indicators of hypromellose capsule in comparison to hard gelatin capsules.
Al-Tabakha MM; Arida AI; Fahelelbom KM; Sadek B; Saeed DA; Abu Jarad RA; Jawadi J
Drug Dev Ind Pharm; 2015; 41(10):1726-37. PubMed ID: 25586554
[TBL] [Abstract][Full Text] [Related]
8. The shell dissolution of various empty hard capsules.
Chiwele I; Jones BE; Podczeck F
Chem Pharm Bull (Tokyo); 2000 Jul; 48(7):951-6. PubMed ID: 10923822
[TBL] [Abstract][Full Text] [Related]
9. Effect of fill weight, capsule shell, and sinker design on the dissolution behavior of capsule formulations of a weak acid drug candidate BMS-309403.
Wu Y; Zhao F; Paborji M
Pharm Dev Technol; 2003; 8(4):379-83. PubMed ID: 14601962
[TBL] [Abstract][Full Text] [Related]
10. The effect of cross-linking on the in vivo disintegration of hard gelatin capsules.
Brown J; Madit N; Cole ET; Wilding IR; Cadé D
Pharm Res; 1998 Jul; 15(7):1026-30. PubMed ID: 9688055
[TBL] [Abstract][Full Text] [Related]
11. Enzymatic activity in the presence of surfactants commonly used in dissolution media, Part 1: Pepsin.
Guzman ML; Marques MR; Olivera Me ME; Stippler ES
Results Pharma Sci; 2016; 6():15-9. PubMed ID: 27047734
[TBL] [Abstract][Full Text] [Related]
12. Cross-linking of gelatin capsules and its relevance to their in vitro-in vivo performance.
Digenis GA; Gold TB; Shah VP
J Pharm Sci; 1994 Jul; 83(7):915-21. PubMed ID: 7965669
[TBL] [Abstract][Full Text] [Related]
13. Effect of glycine/citric acid on the dissolution stability of hard gelatin capsules.
Adesunloye TA; Stach PE
Drug Dev Ind Pharm; 1998 Jun; 24(6):493-500. PubMed ID: 9876614
[TBL] [Abstract][Full Text] [Related]
14. Hard gelatin and hypromellose (HPMC) capsules: estimation of rupture time by real-time dissolution spectroscopy.
El-Malah Y; Nazzal S; Bottom CB
Drug Dev Ind Pharm; 2007 Jan; 33(1):27-34. PubMed ID: 17192248
[TBL] [Abstract][Full Text] [Related]
15. Comparison of WHO and US FDA biowaiver dissolution test conditions using bioequivalent doxycycline hyclate drug products.
Strauch S; Jantratid E; Dressman JB
J Pharm Pharmacol; 2009 Mar; 61(3):331-7. PubMed ID: 19222905
[TBL] [Abstract][Full Text] [Related]
16. The effects of surfactants on the dissolution profiles of poorly water-soluble acidic drugs.
Park SH; Choi HK
Int J Pharm; 2006 Sep; 321(1-2):35-41. PubMed ID: 16797892
[TBL] [Abstract][Full Text] [Related]
17. The effect of gelatin cross-linking on the bioequivalence of hard and soft gelatin acetaminophen capsules.
Meyer MC; Straughn AB; Mhatre RM; Hussain A; Shah VP; Bottom CB; Cole ET; Lesko LL; Mallinowski H; Williams RL
Pharm Res; 2000 Aug; 17(8):962-6. PubMed ID: 11028942
[TBL] [Abstract][Full Text] [Related]
18. Development of a two-step tier-2 dissolution method for blinded overencapsulated erlotinib tablets using UV fiber optic detection.
Lu X; Xiao B; Lo L; Bolgar MS; Lloyd DK
J Pharm Biomed Anal; 2011 Aug; 56(1):23-9. PubMed ID: 21620602
[TBL] [Abstract][Full Text] [Related]
19. Stabilization of hard gelatin capsule shells filled with polyethylene glycol matrices.
Stein D; Bindra DS
Pharm Dev Technol; 2007; 12(1):71-7. PubMed ID: 17484146
[TBL] [Abstract][Full Text] [Related]
20. Enhancing the Dissolution Stability of Hard Gelatin Capsules Using Activated Carbon as a Packaging Component.
Likar MD; Carroll SC; Colgan ST; Yeoh T; MacDonald BC; Johnson GM; Space JS
J Pharm Sci; 2018 Dec; 107(12):3080-3088. PubMed ID: 30145210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
